Analyst consensus rating
Praxis Precision Medicines Analyst Rating: Strong Buy
PRAX is rated Strong Buy by 19 analysts with a $638.68 target. As of 2026-08-28.
Direct answer
Praxis Precision Medicines's consensus rating is Strong Buy.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $638.68.
Forecast evidence checked August 28, 2026.
Get free Praxis Precision Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $348.15
- Average price target
- $638.68
- High price target
- $1,201.00
- Low price target
- $188.00
- Low target gap
- -46%
- Target upside
- +83.5%
- High target gap
- +245%
- Target range width
- 291%
- Consensus rating
- Strong Buy
- Analysts
- 19
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Praxis Precision Medicines?
Praxis Precision Medicines has a verified Strong Buy consensus. The same dataset has an average price target of $638.68.
How far are Praxis Precision Medicines's low and high targets from the recorded price?
The low target implies -46%, while the high target implies +245%.
How many analysts are included in Praxis Precision Medicines's consensus?
The verified consensus includes 19 analysts.
How is Praxis Precision Medicines's target upside or downside calculated?
The average target of $638.68 is divided by the recorded price of $348.15, then one is subtracted to produce +83.5%. This does not guarantee a future return.
When was Praxis Precision Medicines's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.